[{"Assets_0_Q2_USD":"7033471000.0","CIK":"875320","CommonStockSharesConverted_0_Q2_shares":"256671000.0","CommonStockSharesOutstanding_0_Q2_shares":"256671000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.04","EarningsPerShareBasic_2_Q2_USD":"2.09","EarningsPerShareDiluted_1_Q2_USD":"1.03","EarningsPerShareDiluted_2_Q2_USD":"2.06","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"788533000.0","NetIncomeLossConverted_1_Q2_USD":"267427000.0","NetIncomeLossConverted_2_Q2_USD":"536058000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q2_USD":"941293000.0","RevenuesConverted_2_Q2_USD":"1799728000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"5069965000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"259822000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"260015000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"256154000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"255941000.0","filed":"20190801","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20190630","qtrs":"0","uom":"USD"}]